New York, Nov. 02, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the Global Up-Regulated Protein Industry report – https://www.reportlinker.com/p06033198/?utm_source=GNW
4% over the analysis period 2020-2027. Diagnostic Labs, one of the segments analyzed in the report, is expected to register a CAGR of 6.2% and to reach $242.3 million by the end of the analysis period. Taking into account the ongoing post-pandemic recovery, growth in the outpatient clinic segment is adjusted to a revised annual growth rate of 5.3% for the next 7 years.
The US market is valued at US$125.5 million while China is forecast to grow at 9.6% CAGR
The US Upregulated Proteins Market is valued at US$125.5 million in 2020. China, the second largest economy in the world, is forecast to reach a projected market size of US$146.7 million by the year 2027, at a CAGR of 9.6% during the 2020-2027 analysis period. Among the other notable geographic Markets include Japan and Canada, which are forecasting growth of 2.4% and 4.1%, respectively, over the period 2020-2027. Within Europe, growth of approx. 3.4% CAGR is forecast for Germany. Led by countries like Australia, India and South Korea, the Asia-Pacific market is expected to reach $91.4 million by 2027.
Hospital segment is expected to register 4.9% CAGR
In the global hospital segment, the US, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets together make a…
